Effect of lamotrigine on mood and cognition in patients receiving chronic exogenous corticosteroids

E. Sherwood Brown, Alan Frol, Leonardo Bobadilla, Vicki A. Nejtek, Dana C. Perantie, Harminder Dhillon

Research output: Contribution to journalArticlepeer-review

39 Scopus citations


Mood changes, cognitive deficits, and psychosis have been reported during corticosteroid therapy. However, minimal data are available on the treatment of these side effects. This pilot study examined the effect of 12 weeks of open- label lamotrigine treatment (dose: mean = 340 mg/day, SD = 65) on mood and cognition in five patients receiving prescription corticosteroids continuously for at least 6 months before study entry. The participants showed significant improvement in cognition with lamotrigine. Two subjects who met criteria for a current major depressive episode at baseline had baseline-to-exit reductions in scores on the Hamilton Depression Rating Scale of more than 20 points. These pilot data suggest that lamotrigine may be associated with improved mood and performance on cognitive tasks in steroid-treated patients. Larger controlled trials are needed to confirm these preliminary findings.

Original languageEnglish (US)
Pages (from-to)204-208
Number of pages5
Issue number3
StatePublished - 2003

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Applied Psychology
  • Psychiatry and Mental health


Dive into the research topics of 'Effect of lamotrigine on mood and cognition in patients receiving chronic exogenous corticosteroids'. Together they form a unique fingerprint.

Cite this